367 related articles for article (PubMed ID: 22571394)
1. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
Chrysant SG
Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
4. The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy.
Chrysant SG; Sugimoto DH; Lefkowitz M; Salko T; Khan M; Arora V; Shi V
Blood Press Suppl; 2007 Mar; 1():10-7. PubMed ID: 17566314
[TBL] [Abstract][Full Text] [Related]
5. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
Fogari R; Preti P; Lazzari P; Corradi L; Zoppi A; Fogari E; Mugellini A
Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
[TBL] [Abstract][Full Text] [Related]
6. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial.
Yan P; Fan W;
Clin Exp Hypertens; 2014; 36(4):268-74. PubMed ID: 23859303
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Messerli FH; Oparil S; Feng Z
Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
10. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
[TBL] [Abstract][Full Text] [Related]
11. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.
Fogari R; Corea L; Cardoni O; Cosmi F; Porcellati C; Innocenti P; Provvidenza M; Timio M; Bentivoglio M; Bertocchi F; Zoppi A
J Cardiovasc Pharmacol; 1997 Oct; 30(4):497-503. PubMed ID: 9335410
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.
Kuschnir E; Acuña E; Sevilla D; Vasquez J; Bendersky M; Resk J; Glazer R
Clin Ther; 1996; 18(6):1213-24. PubMed ID: 9001838
[TBL] [Abstract][Full Text] [Related]
14. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group.
Frishman WH; RAM CV; McMahon FG; Chrysant SG; Graff A; Kupiec JW; Hsu H
J Clin Pharmacol; 1995 Nov; 35(11):1060-6. PubMed ID: 8626878
[TBL] [Abstract][Full Text] [Related]
15. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
Sapienza S; Sacco P; Floyd K; DiCesare J; Doan QD
Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
[TBL] [Abstract][Full Text] [Related]
17. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
[TBL] [Abstract][Full Text] [Related]
18. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
19. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
20. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
Kountz DS
J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
